VENXXIVA Drug Patent Profile
✉ Email this page to a colleague
When do Venxxiva patents expire, and when can generic versions of Venxxiva launch?
Venxxiva is a drug marketed by Torrent and is included in one NDA.
The generic ingredient in VENXXIVA is tiopronin. There are three drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the tiopronin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Venxxiva
A generic version of VENXXIVA was approved as tiopronin by TEVA PHARMS USA INC on April 26th, 2021.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for VENXXIVA?
- What are the global sales for VENXXIVA?
- What is Average Wholesale Price for VENXXIVA?
Summary for VENXXIVA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Patent Applications: | 2,775 |
| DailyMed Link: | VENXXIVA at DailyMed |
Pharmacology for VENXXIVA
| Drug Class | Reducing and Complexing Thiol |
| Mechanism of Action | Cystine Disulfide Reduction |
US Patents and Regulatory Information for VENXXIVA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Torrent | VENXXIVA | tiopronin | TABLET, DELAYED RELEASE;ORAL | 216990-001 | Jan 30, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Torrent | VENXXIVA | tiopronin | TABLET, DELAYED RELEASE;ORAL | 216990-002 | Jan 30, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
